Envoy Medical (NASDAQ:COCH – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.50) EPS for the quarter, beating analysts’ consensus estimates of ($0.67) by $0.17, FiscalAI reports. The firm had revenue of $0.07 million during the quarter, compared to the consensus estimate of $0.09 million.
Envoy Medical Stock Up 0.7%
COCH traded up $0.05 during midday trading on Friday, hitting $7.15. 50,474 shares of the company were exchanged, compared to its average volume of 21,609. The firm’s 50 day moving average price is $6.82 and its 200-day moving average price is $6.88. Envoy Medical has a 1-year low of $3.63 and a 1-year high of $9.54. The firm has a market capitalization of $55.20 million, a P/E ratio of -1.55 and a beta of 2.03.
Wall Street Analyst Weigh In
COCH has been the topic of a number of research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Envoy Medical in a research report on Monday, October 19th. Lake Street Capital lifted their price target on Envoy Medical from $2.50 to $25.00 and gave the company a “buy” rating in a research note on Tuesday, October 27th. HC Wainwright restated a “buy” rating on shares of Envoy Medical in a report on Tuesday, October 13th. Finally, Loop Capital set a $20.00 price objective on Envoy Medical in a research note on Monday, July 27th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $21.67.
Get Our Latest Analysis on Envoy Medical
Envoy Medical Company Profile
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with sensorineural hearing loss. Unlike conventional hearing aids and many cochlear implants, its technology is designed to be placed beneath the skin, with no external wearable sound processor.
The company’s lead product is the Acclaim Cochlear Implant, a fully implanted cochlear implant intended to address moderate-to-profound sensorineural hearing loss in adults. The system is designed to use the body’s natural anatomy to capture sound and convert it into electrical signals that stimulate the auditory nerve.
See Also
- Five stocks we like better than Envoy Medical
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
